v3.26.1
Segment Information (Tables)
 6 Months Ended
Jun. 30, 2026
Segment Reporting [Abstract]  
Summary of Segment Information for Revenue, Significant Segment Expenses and Net Loss as Regularly Provided to the CODM

The following table presents segment information for revenue, significant segment expenses, and net loss, as regularly provided to the CODM, for the three and six months ended June 30, 2026 and 2025 (in thousands):

 

Three Months Ended

 

 

Six Months Ended

 

 

June 30,

 

 

June 30,

 

 

2026

 

 

2025

 

 

2026

 

 

2025

 

Revenue

$

30

 

 

$

17

 

 

$

44

 

 

$

55

 

Less:

 

 

 

 

 

 

 

 

 

 

 

Cost of revenue

 

50

 

 

 

41

 

 

 

92

 

 

 

81

 

Payroll related expenses

 

5,487

 

 

 

3,992

 

 

 

10,085

 

 

 

7,892

 

Consulting and professional fees

 

1,641

 

 

 

2,042

 

 

 

3,564

 

 

 

3,875

 

Stock-based compensation expense

 

823

 

 

 

1,344

 

 

 

1,658

 

 

 

2,837

 

Equipment, lab supplies, and facility expenses

 

354

 

 

 

434

 

 

 

667

 

 

 

803

 

Clinical studies and outside processing

 

154

 

 

 

430

 

 

 

276

 

 

 

717

 

Depreciation and amortization(1)

 

162

 

 

 

208

 

 

 

326

 

 

 

395

 

Other segment items(2)

 

1,363

 

 

 

846

 

 

 

2,740

 

 

 

2,025

 

Loss from operations

 

(10,004

)

 

 

(9,320

)

 

 

(19,364

)

 

 

(18,570

)

Interest expense

 

(2

)

 

 

(2

)

 

 

(4

)

 

 

(6

)

Other income, net

 

867

 

 

 

1,276

 

 

 

1,830

 

 

 

2,343

 

Net loss

$

(9,139

)

 

$

(8,046

)

 

$

(17,538

)

 

$

(16,233

)

 

(1)
Certain amortization amounts are included within cost of revenue.
(2)
Other segment items consist primarily of insurance costs, IT services, travel expenses, marketing expenses, taxes, and other miscellaneous expenses.